Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension
- 1 December 2002
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 37 (6) , 767-772
- https://doi.org/10.1016/s0168-8278(02)00295-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Evidence for An Endothelium–Derived Hyperpolarizing Factor in the Superior Mesenteric Artery From Rats With CirrhosisHepatology, 2000
- Human urotensin‐II is an endothelium‐dependent vasodilator in rat small arteriesBritish Journal of Pharmacology, 2000
- Human Urotensin-II is a Potent Vasoactive PeptideJournal of Cardiovascular Pharmacology, 2000
- Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: Role in splanchnic hemodynamicsHepatology, 1998
- In Vitro Evidence for Vascular Hyporesponsiveness in Clinical and Experimental CirrhosisPharmacology & Therapeutics, 1997
- Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†Hepatology, 1996
- Plasma levels of substance p in liver cirrhosis: Relationship to the activation of vasopressor systems and urinary sodium excretionHepatology, 1995
- Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertensionHepatology, 1993
- Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosisJournal of Hepatology, 1991
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973